Maybe part of a broader clinical picture your doctor has been missing or hasn't even considered yet, and GLP ones may aid in this
The main risks stem from its unapproved status and potential for improper compounding
Over time, this leads to better body composition, with more lean mass and less fat
Oral GLP-1 removes the largest stated initiation barrier for 43% of obesity patients, expanding the treatment-seeking population by an estimated 60 to 90 million patients within three years
The standard protocol starts at 2.5 mg weekly with gradual escalation every four weeks based on response and tolerability, regardless of gallbladder status
The liver binding, corrected for decreases in liver volume and plasma glucagon levels, decreased from SUV 55min 4.27 (1.02) at baseline to SUV 55min 3.70 (0.59) at follow up (Fig